Myelodysplastic syndromes (MDS) and acute myeloid leukemias (AML) with myelofibrosis.
Acute myeloid leukemias (AML) and myelodysplastic syndromes (MDS) enter rarely in the differential diagnosis of myelofibrosis (MF). MF of marked intensity, resulting in either "dry taps" or non-representative smears, is encountered in approximately 10% of cases. MF may be observed in any type of AML, most frequently in acute megakaryoblastic leukemia (M7). Apart from some typical cases of MDS, MF is associated with cases of acute myelodysplasia with myelofibrosis (and a major megakaryocytic component). This syndrome has been described under various headings: acute or malignant myelosclerosis, and acute MF. It should be distinguished from M7 and from myeloproliferative syndromes.
Imbert
M
M
Laboratory of Hematology-Immunology, Henri Mondor Hospital, Creteil, France.
Nguyen
D
D
Sultan
C
C
D000208:Acute Disease; D003937:Diagnosis, Differential; D006801:Humans; D007947:Leukemia, Megakaryoblastic, Acute / Q000150:complications / Q000175:diagnosis; D007951:Leukemia, Myeloid / Q000150:complications* / Q000175:diagnosis; D009190:Myelodysplastic Syndromes / Q000150:complications* / Q000175:diagnosis; D055728:Primary Myelofibrosis / Q000209:etiology*